• Home
  • All News Articles

FDA approves eculizumab for generalized myasthenia gravis

This study was done in the TraCS' CTRC (Manisha Chopra, study coordinator). UNC's James F. Howard, MD, was the lead investigator in the clinical trial that led to FDA approval. James F. Howard Jr., MD Yesterday the U.S....

A vision to guide Carolina's growth

In its entire 223-year history, Carolina has never had one overarching vision to guide its growth. But that changed last spring when Chancellor Carol L. Folt introduced a new vision — The Blueprint for Next —...

Cradles of Love

UNC researcher partners with NC State industrial design students to create innovative new bassinetWith the growing trend of keeping newborns in their mother's hospital room post-delivery, hospitals must ensure that mothers...

Carolina creates UNC Institute for Convergent Science

With the Institute for Convergent Science, Carolina will lead the world in bringing scientific expertise together to improve people's lives, Chancellor Carol L. Folt said. "The UNC Institute for Convergent Science will be...

View news related to policies and regulations

Have news or an announcement to share? Contact Michelle Maclay at michelle_maclay@med.unc.edu

Get NC TraCS events and news delivered to your inbox! Subscribe to our weekly email blast

NC TraCS Institute logo vertical

In partnership with:

Contact Us


Brinkhous-Bullitt, 2nd floor
160 N. Medical Drive
Chapel Hill, NC 27599

919.966.6022
This email address is being protected from spambots. You need JavaScript enabled to view it.

Social


Cite Us


CitE and SUBMit CTSA Grant number - UM1TR004406

© 2008-2024 The North Carolina Translational and Clinical Sciences (NC TraCS) Institute at The University of North Carolina at Chapel Hill
The content of this website is solely the responsibility of the University of North Carolina at Chapel Hill and does not necessarily represent the official views of the NIH   accessibility | contact